KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Non-cash Items (2016 - 2019)

NovoCure's Non-cash Items history spans 5 years, with the latest figure at $4.3 million for Q2 2019.

  • For Q2 2019, Non-cash Items fell 27.0% year-over-year to $4.3 million; the TTM value through Jun 2019 reached $4.3 million, down 27.0%, while the annual FY2018 figure was $287.7 million, 97.39% up from the prior year.
  • Non-cash Items for Q2 2019 was $4.3 million at NovoCure, down from $5.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $287.7 million in Q4 2018 and bottomed at $4.3 million in Q2 2019.
  • The 5-year median for Non-cash Items is $6.1 million (2017), against an average of $44.3 million.
  • The largest annual shift saw Non-cash Items crashed 95.93% in 2016 before it soared 617.93% in 2017.
  • A 5-year view of Non-cash Items shows it stood at $144.7 million in 2015, then tumbled by 85.96% to $20.3 million in 2016, then skyrocketed by 617.93% to $145.8 million in 2017, then soared by 97.39% to $287.7 million in 2018, then crashed by 98.49% to $4.3 million in 2019.
  • Per Business Quant, the three most recent readings for NVCR's Non-cash Items are $4.3 million (Q2 2019), $5.9 million (Q1 2019), and $287.7 million (Q4 2018).